Introduction
Gastric epithelial dysplasia and gastric adenomas have been considered to be precancerous lesions with a variable clinical course. Some progress to adenocarcinomas, whereas others persist unchanged for a long time [1, 2] . The absence of a uniform classifi cation for gastric epithelial dysplasia/gastric adenomas has caused confusion regarding the features that differentiate preinvasive from early gastric cancer lesions. This diagnostic inconsistency leads to inappropriate treatment and has often resulted in overtreatment of gastric mucosal neoplasias by surgical resection [3, 4] . Therefore, a uniform classifi cation is needed, with reproducible criteria that have minimal inter-and intraobserver variability.
For the practicing physician, the classifi cation should be simple and refl ect the available therapeutic options. Since 2000, the revised Vienna classifi cation has helped to provide guidance for clinical management [5, 6] . The removal of category 3 lesions (low-grade dysplasia), based on that classifi cation, is not necessary, whereas the removal of category 4 lesions (high-grade dysplasia and intramucosal cancer) is obligatory, because more than 80% of high-grade adenomas progress to adenocarcinomas [7] . However, there are frequently cases that do not easily fi t into the diagnostic categories; 15%-30% of low-grade adenomas progress to high-grade adenomas or adenocarcinomas [8, 9] . Therefore, it is diffi cult for clinicians to determine which low-grade adenomas will progress. To date, only a few studies have determined the risk factors for malignant transformation of gastric epithelial dysplasias, stratifi ed by subgroups specifi c for the dysplastic grade [10, 11] . The goal of the present study was to compare the endoscopic fi ndings, pathology of the surrounding mucosa, and the immunophenotype of category 3 lesions (low-grade dysplasia) with these fi ndings in category 4 (high-grade dysplasia and intramucosal cancer) lesions, according to the revised Vienna classifi cation.
The Runt family of transcription factors consists of three members: RUNX1, RUNX2, and RUNX3. All three RUNXs play important roles in both normal developmental processes and carcinogenesis [12] . Especially, RUNX3 is necessary for the suppression of cell proliferation of the gastric epithelium. It is known that primary gastric cancer specimens express signifi cantly lower levels of RUNX3 than normal tissue, because RUNX3 exerts its tumor suppressor activity [13, 14] . We explored the role of RUNX3 in early gastric carcinogenesis.
Methods

Materials
Human samples were used according to the guidelines of the Ethics Committee of the Catholic University of Korea. All tissues were therapeutically excised by endoscopic mucosal resection from May 2004 to June 2008. The diagnosis of the tissue samples, according to the revised Vienna classifi cation, was confi rmed by two different histopathologists; when they disagreed, the tissue sample was excluded from the study.
Endoscopic fi ndings of gastric epithelial neoplasia
Two different specialists re-evaluated the endoscopic fi ndings by reviewing the imaging archiving communication system. The lesion variables analyzed were the size (largest diameter), type (prominent, fl at, or depressed), color change (red, white, or no change), ulceration (presence or absence), location of the lesion (antrum or body), and the extent of atrophy (closed or open type).
Pathology examination of surrounding mucosa
All normal surrounding tissues examined were grossly intact mucosa at least 1 cm from the mucosal lesion that had been removed as gastric biopsy specimens just after endoscopic mucosal resection. Microscopic examination showed no evidence of malignant cells. Each patient was classifi ed as Helicobacter pylori-positive or -negative according to the histological results (silver stain or CLO test).
To evaluate the pathological association between gastric cancer and gastritis patterns, we focused on the infl ammation of the gastric mucosa adjacent to the lesions. A gastritis score was calculated for the surrounding mucosa, based on the summed values of the grade and the activity of gastritis. Grading of the variables associated with gastritis (infi ltration by lymphocytes and plasma cells) was performed using the updated Sydney system [15] , a scoring system ranging from 0 = none to 3 = severe. Gastritis activity was based on infi ltration by neutrophilic granulocytes and was scored according to the updated Sydney system. Intestinal metaplasia was noted as absent, complete, or incomplete.
Immunohistochemical staining of CD10, MUC2, MUC5AC, MUC6, and RUNX3
All mucosal tissues were immediately fi xed in 10% buffered formalin and routinely processed. For each tissue block, 4-μm-thick serial, paraffi n-embedded tissue sections were cut and stained with hematoxylin and eosin. Sections containing glandular epithelium were selected for this study. The samples were deparaffi nized in xylene and rehydrated in graded ethanol. Endogenous peroxidase activity was blocked with 3% H 2 O 2 in phosphatebuffered saline. For antigen retrieval, the sections were incubated in 10 mM citrate buffer (pH 6.0), using a microwave oven, and then incubated with primary antibodies. The primary antibodies used were: MUC2 (1: 200, clone Ccp58, monoclonal; Novocastra Laboratories, Newcastle upon Tyne, UK), MUC5AC (1: 100, clone CLH2, monoclonal; Novocastra Laboratories), MUC6 (1: 100, clone CLH5, monoclonal; Novocastra Laboratories), CD10 (1: 400, clone 56C6, monoclonal; Novocastra Laboratories), and RUNX3 (1: 200, AMC-2/RUNX3 rabbit polyclonal antibody; Active Motif, Carlsbad, CA, USA). Antibody detection was performed using the IMPRESS peroxidase reagent kit (Vector Laboratories, Burlingame, CA, USA) according to the manufacturer's protocol. Immunoreactive cells were identifi ed using a DAB peroxidase substrate kit (Vector Laboratories). The sections were counterstained with hematoxylin.
Assessment of immunohistochemical staining
The results of immunostaining for CA10, MUC2, MUC5AC, MUC6, and RUNX3 were considered positive if more than 10% of the tumor cells were stained [16] [17] [18] . The expressions of MUC2 and CD10 were examined as markers for intestinal phenotypes and MUC6 and MUC5AC expressions were considered as markers for gastric phenotypes. The cellular mucin phenotypes were classifi ed according to the combined expression patterns of the gastric markers and intestinal markers, as four phenotypes: gastric type (tumor cells were positive for either MUC6 or MUC5AC, and negative for both MUC2 and CD10; G type), intestinal type (tumor cells were positive for either MUC2 or CD10, and negative for both MUC6 and MUC5AC; I type), mixed type (tumor cells were positive for both gastric and intestinal markers; M type), and an unclassifi ed phenotype (tumor cells were negative for both gastric and intestinal markers; N type) [10, 19] .
Statistical analysis
For the quantitative variables, the mean values and SD were calculated. For the qualitative variables, the percentages and their 95% confi dence intervals (95% CIs) were calculated. For comparisons of age and gastritis scores, we used the unpaired t-test and one-way analysis of variance (ANOVA). In addition, the χ 2 test and linear by linear association was used to investigate the association with other variables (H. pylori status, endoscopic and pathological fi ndings, and immunological results). A binary logistic regression model was used for multivariate analysis. The SPSS statistical package software for Windows release 12.0 (SPSS, Chicago, IL, USA) was used for all analyses. Signifi cance was defi ned as a P value of less than 0.05.
Results
A total of 120 tissue samples were analyzed and 14 tissue samples were excluded because of disagreement about the diagnosis or because of inappropriate preparation of tissue samples. The concordance rate between the two histopathologists was 88.3%. The data of the remaining 106 patients with gastric epithelial dysplasia and intramucosal cancer were evaluated for this study. 
Endoscopic characteristics of gastric epithelial neoplasia
We reviewed the data on the type, size, color change, ulceration, and location of the lesions by using the imaging archiving communication system. The category 4 lesions were signifi cantly associated with larger size lesions, red color changes, and the presence of ulceration. The distribution of lesion locations was similar in category 4 and category 3 lesions (Table 1) .
Patterns of gastritis in the surrounding mucosa evaluated by pathological and endoscopic fi ndings
The gastritis scores for category 3 and 4 lesions were 2.27 ± 0.95 and 2.69 ± 1.10, respectively; category 4 lesions had higher values than category 3 lesions (P = 0.04). The other variables, including status of H. pylori, intestinal metaplasia, and the morphometric changes of gastric mucosal atrophy did not show signifi cant differences ( Table 2) .
Immunoreactivity of MUC2, MUC5AC, MUC6, and CD10
The microscopic features of the immunohistochemical staining for MUC2, MUC5AC, MUC6, and CD10 are presented in Figs 1 and 2 . Of the 52 cases included in category 3, MUC2, MUC5AC, MUC6, and CD10 were expressed in 30 (57.7%), 15 (28.8%), 3 (5.8%), and 20 (38.5%) cases, respectively. Of the 54 cases included in category 4, MUC2, MUC5AC, MUC6, and CD10 were expressed in 32 (59.3%), 22 (40.7%), 14 (25.9%), and 18 (33.3%) cases, respectively. MUC6 expression was more frequently observed in category 4 than in category 3 lesions (P = 0.005; Table 3 ). When the lesions were subgrouped into high-grade dysplasia (category 4.1) and intramucosal cancer (category 4.4), positive expression of MUC6 was observed in 7 cases (7/36; 19.4%), and 7 cases (7/19; 36.8%), respectively (P = 0.002). Taking into account the combination of expression of the gastric (MUC6 and MUC5AC) and intestinal (MUC2 and CD10) markers, the gastric epithelial neoplasias were classifi ed into four mucin phenotypes. For category 3 
Immunoreactivity of RUNX3
The microscopic features of RUNX3 immunohistochemical staining are presented in Fig. 3 
Multivariate analysis
Multivariate analysis of the covariates that showed statistical signifi cance in the univariate analysis was performed; the results showed that a diameter of more than 17 mm, the presence of ulceration and positive expression of MUC6 were strongly associated with category 4 lesions ( Table 4) .
Discussion
With the increasing use of endoscopic therapy such as endoscopic mucosal resection, it is very important to agree on the diagnosis of gastric epithelial neoplasia. After the revised Vienna classifi cation was introduced, agreement on the diagnosis improved to 80% for gastric lesions [20] . However, this classifi cation is not perfect and it requires the consideration of additional information, including endoscopic fi ndings, pathology, and immunological feature, as well as molecular markers. In addition, the frequency of discrepant diagnoses between biopsy specimens and the corresponding resected specimens of the same lesions has ranged from 20% to 40% in previous reports [21] [22] [23] . In the clinical setting, many physicians have diffi culty with decisions on their therapeutic plan because of uncertainty with regard to the interpretation of biopsy reports. Therefore, complete removal of the entire epithelial lesion is recommended to confi rm the diagnosis. In the present study, we attempted to eliminate diagnostic bias in the biopsy specimen and evaluated specimens excised by endoscopic mucosal resection. Identifi cation of a gastric adenoma that has the potential to progress to cancer is an important consideration for the therapeutic plan. In general, the risk of malignant transformation, for an adenoma, depends on its size, histological type, and the presence of atrophy [24] [25] [26] . The tumor size is considered to be an important prognostic marker; however, several studies have not provided evidence to support the importance of this variable [24, 27] . Our present results showed that by univariate analysis, the size of the lesion, red color changes, presence of ulceration, gastritis score of the surrounding mucosa, and immunoreactivity of MUC6 were risk factors for malignant change. The multivariate analysis showed that the size of the lesion, ulceration, and immunoreactivity of MUC6 were associated with early changes of malignancy. Especially for macroscopic examination, the lesion size and presence of ulceration are simple and important factors that can be used for reaching therapeutic decisions; assessment of these factors might help reduce the overtreatment of lesions such as surgical treatment of low grade adenoma.
Mucins are the main structural components of mucus; they are highly glycosylated, high-molecular weight glycoproteins [28] . In general, normal gastric epithelium of the antrum is characterized by the expression of secretory mucins: MUC5AC and MUC6. Intestinal metaplasia of the stomach is characterized by the expression of MUC2 and CD10, whereas the expression of MUC5AC and MUC6 is reduced in intestinal metaplasia [29, 30] . Moreover, H. pylori-infected gastric surface epithelium protects itself by the downregulation of MUC5AC and the upregulation of MUC6; this process forms a mucus gel-layer to protect the underlying epithelium [31, 32] . The phenotypic expression of tumor markers is thought to imitate the tissue of origin; such expression of tumor markers is associated with tumor aggressiveness in advanced gastric cancer [33] . It is known that malignant transformation from a gastric adenoma to a carcinoma is signifi cantly associated with the gastric and the intestinal mixed phenotypes [34, 35] . Our present results revealed that the gastric and mixed phenotypes were increased in category 4 lesions compared with fi ndings in the category 3 lesions; however, these differences did not reach statistical signifi cance. In a recent report, phenotypic marker expression was closely associated with genetic alterations, especially microsatellite instability, which is signifi cantly associated with MUC6 expression. Moreover, MUC6 is upregulated by nuclear factor (NF)-κB, a nuclear transcription factor that is also activated in infl ammatory and neoplastic conditions [36] [37] [38] . It is noteworthy that positive immunoreactivity of MUC6 was found to be a risk factor for malignant change by the univariate and multivariate analyses in the present study. Positive immunoreactivity of MUC6 in the areas of gastric epithelial neoplasia with highgrade dysplasia and intramucosal cancer suggests that MUC6 might play a role in malignant transformation, and MUC6 might be a useful marker for distinguishing lesions at risk of malignant transformation. However, to clarify these risk factors, a different study plan would be required; that is, a prospective or retrospective study would be needed to examine whether or not category 3 lesions, determined by biopsy diagnosis, associated with any of the factors demonstrated in the present study (size more than 17 mm, ulceration, MUC6 expression), had developed to category 4 lesions.
Gastric infl ammation is already considered a risk factor for gastric carcinoma [39, 40] . Previously, Correa [41] postulated that chronic gastritis may lead to intestinal metaplasia and atrophy, and noted that these fi ndings should be considered a risk factor for the development of cancer, because they are frequently found to be closely related to cancer. Herein we focused on the acute and chronic infl ammation around gastric epithelial neoplasias and investigated these fi ndings with regard to malignant changes. Contrary to the fi ndings in a previous study [42] , we divided intestinal metaplasia (IM) into three categories: absent, incomplete, and complete IM and evaluated them as independent variables. IM has been extensively studied as a precancerous lesion of the human stomach; it has been shown to have a strong association with the development of stomach cancer [43] [44] [45] [46] . Gastric atrophy is defi ned as the loss of specialized glands; however, there is essentially no agreement among pathologists on the assessment of gastric atrophy. One goal of the present study was to increase interobserver agreement on atrophy by using a morphometric diagnosis that corresponds to a serological gastric profi le of atrophy, as previously reported [47] . Our results showed that IM and atrophy were not signifi cantly different. However, the activity and grade of gastritis in category 4 lesions had higher values than those in category 3 lesions. Considering that H. pylori is recognized as the major pathogenetic factor associated with chronic active gastritis, the eradication of this bac-terium should help block the progression of gastric dysplasia. Whether H. pylori eradication is benefi cial at the dysplastic stage of the gastric epithelium requires further study.
RUNX3 is a novel tumor suppressor gene; it is frequently silenced in gastric cancers by the hypermethylation of CpG islands in the exon 1 region [12, 13, 48] . Immunohistochemistry results showed the RUNX3 protein in most chief cells and in a few gastrin-containing G cells in normal mucosa, but not in IM or carcinoma cells [49] . Although RUNX3 immunoreactivity showed no signifi cant difference between category 3 and 4 lesions in the present study, negative expression of RUNX3 was more frequent in intramucosal cancers than in dysplasias. The loss of function of RUNX3 might be a very early event in the progression of gastric carcinogenesis.
In conclusion, the size, color change, ulceration, gastritis score of the surrounding mucosa, and positive expression of MUC6 were signifi cant variables that might be involved in the malignant transformation of gastric dysplasia. The fi ndings of a lesion more than 17 mm in diameter or ulceration are important factors to consider for therapeutic decisions. In addition, MUC6 expression may be a novel marker for the risk of malignant change.
